caselaw.findlaw.com/us-3rd-circuit/1313639.html

ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...

law.justia.com/cases/federal/appellate-courts/ca1/15-2232/15-2232-2017-05-02.html

May 8, 2017 ... Plaintiff appealed the district court's grant of summary judgment in favor of her former employer, AstraZeneca Pharmaceutical LP, on Plaintiff's ...

www.todaysworkplace.org/2005/03/15/for-once-an-ada-case-that-inspires-instead-of-depresses

Mar 15, 2005 ... Emory v. AstraZeneca, recently decided by the 3rd Circuit Court of Appeals, ... which essentially penalized him for all of his accomplishments in ...

casetext.com/case/united-states-v-astrazeneca-biopharmaceuticals-inc

Apr 17, 2017 ... Astrazeneca Biopharmaceuticals, Inc. ... PLC; Astrazeneca, LP; and Astrazeneca Pharmaceuticals, LP (together, ... AstraZeneca, et al., No.

www.ncbi.nlm.nih.gov/pmc/articles/PMC6302998

Mar 1, 2018 ... Journal List · J Adv Pract Oncol · v.9(2); 2018 Mar; PMC6302998 ..... EGFR TKIs ( AstraZeneca Pharmaceuticals LP, 2015b; Jänne et al., 2015; Table 1). ..... Li Jing, Karlsson Mats O, Brahmer Julie, Spitz Avery, Zhao Ming, ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5471856

May 11, 2016 ... Find articles by Ming Zhou .... Ratner et al., 2002 [13], Type 2 diabetesb requiring insulinc; mean age ..... and long-term glycemic control (−0.6 % HbA1c reduction vs. placebo [12, ... by Amylin Pharmaceuticals, a wholly owned subsidiary of AstraZeneca. .... Wilmington, DE: AstraZeneca Pharmaceuticals LP.

www.fct-cf.gc.ca/fc_cf_en/National_List.html

Mar 16, 2018 ... T-1668-10, ASTRAZENECA CANADA INC. ET AL v. APOTEX INC. ... T-998-16, SHIRE PHARMA CANADA ULC v. APOTEX INC. ET AL. ...... IMM-4361-17, MING ZHANG v. ..... T-2224-16, VALEANT CANADA LP ET AL v.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2963920

Oct 21, 2010 ... Saxagliptin significantly improves glycemic control vs placebo, ... Saxagliptin ( Onglyza™; Bristol-Myers Squibb Company, Princeton, NJ, USA; AstraZeneca Pharmaceuticals LP, Wilmington, DE, ..... Volume 25 by Rosenstock, et al. ..... Kirby M, Ming Tse Yu D, O'Connor S, Gorrell M. Inhibitor selectivity in the ...